tiprankstipranks
Heron Therapeutics Inc (HRTX)
NASDAQ:HRTX
US Market
HRTX
Heron Therapeutics
RESEARCH TOOLSreports

Heron Therapeutics (HRTX) Income Statement

1,638 Followers

Heron Therapeutics Income Statement

Last quarter (Q4 2025), Heron Therapeutics's total revenue was $40.59M, a decrease of -0.47% from the same quarter last year. In Q4, Heron Therapeutics's net income was $-2.95M. See Heron Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 154.90M$ 144.28M$ 127.04M$ 107.67M$ 86.35M
Gross Profit
$ 113.56M$ 105.64M$ 61.94M$ 52.80M$ 40.33M
Operating Expenses
$ 116.09M$ 117.17M$ 172.55M$ 227.46M$ 258.15M
Depreciation and Amortization
$ 2.31M$ 2.49M$ 2.90M$ 2.89M$ 3.02M
EBITDA
$ -17.88M$ -5.06M$ -103.79M$ -176.66M$ -215.25M
Operating Income
$ -2.54M$ -11.53M$ -110.61M$ -174.66M$ -217.83M
Other Income/Expenses
$ -17.66M$ -2.05M$ 56.00K$ -7.37M$ -2.85M
Pretax Income
$ -20.20M$ -13.58M$ -110.56M$ -182.02M$ -220.68M
Net Income
$ -20.20M$ -13.58M$ -110.56M$ -182.02M$ -220.68M
Per Share Metrics
Basic EPS
$ -0.12$ -0.09$ -0.80$ -1.67$ -2.24
Diluted EPS
$ -0.12$ -0.09$ -0.80$ -1.67$ -2.24
Weighted Average Shares Outstanding
 166.71M 152.45M 138.13M 109.00M 98.47M
Weighted Average Shares Outstanding (Diluted)
 166.71M 152.45M 138.13M 109.00M 98.47M
Currency in USD

Heron Therapeutics Earnings and Revenue History